Published: March 19, 2010
Mayo Research: Intervention Drops Hospital Infection Rate by One-Third
ROCHESTER, Minn. - (BUSINESS WIRE) - Clostridium difficile (C. difficile) is the one of the leading pathogens
causing hospital-acquired infection in the United States. It may cause
diarrhea, colitis, sepsis and lead to prolonged hospitalization and
death. Mayo Clinic researchers say they've found a way to reduce the
acquisition of this infection and drop its frequency to a fraction of
what it had been.
The process involves consistent daily cleaning of all high-touch
surfaces with a spore-killing bleach disinfectant wipe for all patients
on units with high endemic rates of C. difficile infection. The findings
are being presented today at a conference in Atlanta sponsored by the
Society for Healthcare Epidemiology of America, the Infectious Diseases
Society of America and the Centers for Disease Control and Prevention.
"The goal was to reduce hospital-acquired C. difficile infection rates
in two of our highest-incidence units by 30 percent," says lead
investigator Robert Orenstein, D.O. "Our data show we far exceeded that.
When the study concluded near the end of last year, one unit had gone
137 days without a hospital-acquired C. difficile infection." The team
had hoped to increase the time between hospital-acquired cases to more
than 20 days between infections.
The hospital rooms in the study were part of two units that housed
general, gastrointestinal and pulmonary disease patients, averaging 39
patients a day. Each of these units has had high endemic rates of this
infection. When the study began, one unit's infection frequency was 61
per 10,000 patient days. The other was higher, at 106 cases per 10,000
patient days. The bleach wipes - containing 0.55 percent sodium
hypochlorite - were selected because the bleach solution is the only
product registered with the U.S. Environmental Protection Agency as
effective against C. difficile spores.
Patients and staff tolerated this daily cleaning with the bleach wipes
without significant concerns. Researchers concluded that this type of
disinfection process was effective at reducing C. difficile infections
on these units and should be instituted in other hospital units with
high infection rates.
The study was initiated, designed and financed by Mayo Clinic. Others on
the research team were Leslie Fedraw, Kimberly Aronhalt, R.N., and James
McManus, all of Mayo Clinic.
About Mayo Clinic
For more than 100 years, millions of
people from all walks of life have found answers at Mayo Clinic. These
patients tell us they leave Mayo Clinic with peace of mind knowing they
received care from the world's leading experts. Mayo Clinic is the first
and largest integrated, not-for-profit group practice in the world. At
Mayo Clinic, a team of specialists is assembled to take the time to
listen, understand and care for patients' health issues and concerns.
These teams draw from more than 3,700 physicians and scientists and
50,100 allied staff that work at Mayo Clinic's campuses in Minnesota,
Florida, and Arizona; and community-based providers in more than 70
locations in southern Minnesota, western Wisconsin and northeast Iowa.
These locations treat more than half a million people each year. To best
serve patients, Mayo Clinic works with many insurance companies, does
not require a physician referral in most cases and is an in-network
provider for millions of people. To obtain the latest news releases from
Mayo Clinic, go to www.mayoclinic.org/news.
For information about research and education, visit www.mayo.edu.
MayoClinic.com (www.mayoclinic.com)
is available as a resource for your general health information.

Mayo Clinic
Robert Nellis
507-284-5005 (days)
507-284-2511
(evenings)
e-mail: newsbureau@mayo.edu
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News